The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease
Open Access
- 22 April 2012
- journal article
- review article
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2012, 1-12
- https://doi.org/10.1155/2012/181394
Abstract
Cardiovascular disease is a complex disorder involving multiple pathophysiological processes, several of which involve activation of toll-like receptors (TLRs) of the innate immune system. As sentinels of innate immunity TLRs are nonclonally germline-encoded molecular pattern recognition receptors that recognize exogenous as well as tissue-derived molecular dangers signals promoting inflammation. In addition to their expression in immune cells, TLRs are found in other tissues and cell types including cardiomyocytes, endothelial and vascular smooth muscle cells. TLRs are differentially regulated in various cell types by several cardiovascular risk factors such as hypercholesterolemia, hyperlipidemia, and hyperglycemia and may represent a key mechanism linking chronic inflammation, cardiovascular disease progression, and activation of the immune system. Modulation of TLR signaling by specific TLR agonists or antagonists, alone or in combination, may be a useful therapeutic approach to treat various cardiovascular inflammatory conditions such as atherosclerosis, peripheral arterial disease, secondary microvascular complications of diabetes, autoimmune disease, and ischemia reperfusion injury. In this paper we discuss recent developments and current evidence for the role of TLR in cardiovascular disease as well as the therapeutic potential of various compounds on inhibition of TLR-mediated inflammatory responses.Keywords
This publication has 94 references indexed in Scilit:
- Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complicationsMetabolism, 2011
- Unexpected protective role for Toll-like receptor 3 in the arterial wallProceedings of the National Academy of Sciences of the United States of America, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanismCardiovascular Research, 2010
- Intravenous immunoglobulins – understanding properties and mechanismsClinical and Experimental Immunology, 2009
- Innate Immunity and Toll‐like Receptor Antagonists: A Potential Role in the Treatment of Cardiovascular DiseasesCardiovascular Therapeutics, 2009
- Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Biological activities of C1 inhibitorMolecular Immunology, 2008
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Toll-like receptor signallingNature Reviews Immunology, 2004